Search results
Earnings call: DiaMedica Therapeutics discusses Q1 progress and challenges By Investing.com
Investing.com· 1 day agoThe company is focused on ramping up site activation and participant enrollment for its ReMEDy2...
Sheffield DocFest Announces 2024 Lineup, Including Tilda Swinton Feature Directorial Debut, Talks By...
Deadline via Yahoo News· 6 days agoUPDATED with amended description of documentary My Sweet Land. Sheffield DocFest, the U.K.’s...
LiveOne (Nasdaq: LVO) Hits New Milestones
NewMediaWire via Yahoo Finance· 11 hours ago- Surpasses 3.75M Total Members a +26% YoY Increase; Adds Record 62K New Paid Members in April- Tesla Membership Tops 1.76M a +31% YoY Increase- Expects...
Earnings call: Vaxart posts progress in vaccine trials, Q1 financials By Investing.com
Investing.com· 1 day agoVaxart, Inc. (NASDAQ: NASDAQ:VXRT), a biotechnology company specializing in the development of oral...
Icahn Enterprises L.P. Announces Upsizing and Pricing of Senior Notes
The Harrisonburg Daily News-Record· 1 day agoIcahn Enterprises L.P. (NASDAQ: IEP) – Icahn Enterprises L.P. ("Icahn Enterprises") announced today that it, together with Icahn Enterprises Finance Corp. (together with Icahn ...
Red Lobster abruptly closes dozens of restaurants across US. See the full list
WFMZ Eastern Pennsylvania and Western New Jersey· 11 hours agoStruggling Red Lobster is abruptly closing dozens of its restaurants around the country, according...
Looking back at former Trump fixer on the stand in hush money trial: Who is Michael Cohen?
USA TODAY via Yahoo News· 1 day agoHe started his sentence in May 2019, but was sent home early for house arrest due to the COVID-19 pandemic. Where did Michael Cohen go to law school? Michael ...
Earnings call: Vaxart posts progress in vaccine trials, Q1 financials By Investing.com
Investing.com· 1 day agoVaxart, Inc. (NASDAQ: NASDAQ:VXRT), a biotechnology company specializing in the development of oral...
American Express Stock Still Looks Attractive Despite Soaring 29% This Year
Motley Fool via Yahoo Finance· 2 days agoThe company has increased its dividend at rates between 17% and 21% each year since 2022. Further,...
Earnings call: DiaMedica Therapeutics discusses Q1 progress and challenges
Investing.com· 2 days agoThe company is focused on ramping up site activation and participant enrollment for its ReMEDy2...